NEW YORK, Dec. 18, 2024 (GLOBE NEWSWIRE) -- MiNK Therapeutics, Inc. (NASDAQ: INKT), a clinical-stage biopharmaceutical company pioneering the discovery, development, and commercialization of ...
ASCO-GI 2025 Presentation Details Title ... the risks and uncertainties related to manufacturing and supply of Coherus’ products, the risks and uncertainties of the regulatory approval process ...
Advancing gastrointestinal cancer pipeline underscores potential for additional registration-enabling studies SAN DIEGO and CALGARY, AB, Dec. /PRNewswire/ -- Oncolytics B ...
BI-1910 single agent Phase 1 Part A dose escalation has been completed and reached a biologically active dose level. Data show stable disease as best clinical response with no notable adverse events ...
LUND, SWEDEN / ACCESSWIRE / January 8, 2025 / BioInvent International (STO:BINV)BI-1910 single agent Phase 1 Part A dose escalation has been completed and reached a biologically active dose level. Dat ...
Verastem, Inc. is on the verge of FDA approval for their combo therapy avutometinib-defactinib, targeting low-grade serous ...
INR:3583. ice princess actress CStone, Alphamab Oncology, Innovent, Cosun Pharmaceutical... Chinese pharmaceutical companies are here at ASCO! Rongchang Biop ...
The global Industrial Valves and Actuators market, valued at approximately USD 123.63 billion in 2022, is expected to grow at a compound annual growth rate (CAGR) of more than 4.14% during the ...
Uliledlimab (TJ004309) is an antibody designed to target CD73, the rate-limiting enzyme critical for adenosine-driven immunosuppression in the tumor microenvironment. I-Mab owns worldwide rights to ...
“We look forward to sharing the final data from this Phase 2 combination study of casdozo with standard of care with the medical community at the upcoming 2025 ASCO-GI annual meeting ... and ...
ASCO has been awarded a five-year contract for base and logistics services for Aker BP in Tananger, Sandnessjøen and Farsund in Norway. The agreement also includes continued services in warehouse ...